AlloVir, Inc. (ALVR) Financial Statements (2024 and earlier)

Company Profile

Business Address 1100 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:233,800,000248,120,000356,324,000
Cash and cash equivalents106,092,000201,661,000122,661,000
Short-term investments127,703,00046,459,000233,663,000
Other undisclosed cash, cash equivalents, and short-term investments5,000  
Receivables157,00050,000450,000
Other undisclosed current assets9,095,0005,178,0004,543,000
Total current assets:243,052,000253,348,000361,317,000
Noncurrent Assets
Operating lease, right-of-use asset31,633,00029,743,0008,692,000
Property, plant and equipment930,0001,549,000812,000
Restricted cash and investments852,000  
Other noncurrent assets612,000  
Other undisclosed noncurrent assets  1,954,000 
Total noncurrent assets:34,027,00033,246,0009,504,000
TOTAL ASSETS:277,079,000286,594,000370,821,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,989,00029,520,0008,493,000
Taxes payable1,007,000 
Accounts payable3,004,0008,361,000963,000
Accrued liabilities13,985,00020,152,0007,530,000
Due to related parties56,0001,742,000572,000
Other undisclosed current liabilities7,293,0006,591,0003,229,000
Total current liabilities:24,338,00037,853,00012,294,000
Noncurrent Liabilities
Long-term debt and lease obligation:  23,475,0005,463,000
Liabilities, other than long-term debt28,222,000  
Operating lease, liability28,222,00023,475,0005,463,000
Other undisclosed noncurrent liabilities  (23,475,000)(5,463,000)
Total noncurrent liabilities:28,222,00023,475,0005,463,000
Total liabilities:52,560,00061,328,00017,757,000
Equity
Equity, attributable to parent224,519,000225,266,000353,064,000
Common stock9,0007,0007,000
Additional paid in capital690,753,000522,479,000478,272,000
Accumulated other comprehensive loss(468,000)(155,000)(112,000)
Accumulated deficit(465,775,000)(297,065,000)(125,103,000)
Total equity:224,519,000225,266,000353,064,000
TOTAL LIABILITIES AND EQUITY:277,079,000286,594,000370,821,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Operating expenses(171,202,000)(169,818,000)(71,309,000)
Operating loss:(171,202,000)(169,818,000)(71,309,000)
Nonoperating income (expense)2,227,000(1,137,000)1,525,000
Investment income, nonoperating1,876,0001,315,0001,330,000
Other nonoperating income (expense)351,000(2,452,000)195,000
Loss from continuing operations before income taxes:(168,975,000)(170,955,000)(69,784,000)
Income tax expense (benefit)265,000(1,007,000) 
Loss from continuing operations:(168,710,000)(171,962,000)(69,784,000)
Loss before gain (loss) on sale of properties:(171,962,000)(69,784,000)
Net loss available to common stockholders, diluted:(168,710,000)(171,962,000)(69,784,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(168,710,000)(171,962,000)(69,784,000)
Other comprehensive income (loss)(313,000)(43,000)(180,000)
Comprehensive loss, net of tax, attributable to parent:(169,023,000)(172,005,000)(69,964,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: